Outlook Therapeutics (OTLK) Current Assets: 2015-2020
Historic Current Assets for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $28.2 million.
- Outlook Therapeutics' Current Assets rose 50.11% to $28.2 million in Q2 2020 from the same period last year, while for Jun 2020 it was $28.2 million, marking a year-over-year increase of 50.11%. This contributed to the annual value of $13.5 million for FY2019, which is 308.83% up from last year.
- According to the latest figures from Q2 2020, Outlook Therapeutics' Current Assets is $28.2 million, which was up 197.65% from $9.5 million recorded in Q1 2020.
- In the past 5 years, Outlook Therapeutics' Current Assets registered a high of $28.2 million during Q2 2020, and its lowest value of $854,681 during Q1 2017.
- For the 3-year period, Outlook Therapeutics' Current Assets averaged around $10.4 million, with its median value being $8.2 million (2018).
- In the last 5 years, Outlook Therapeutics' Current Assets crashed by 92.01% in 2017 and then skyrocketed by 1,005.49% in 2018.
- Outlook Therapeutics' Current Assets (Quarterly) stood at $3.2 million in 2016, then surged by 383.53% to $15.3 million in 2017, then crashed by 84.98% to $2.3 million in 2018, then skyrocketed by 183.71% to $6.5 million in 2019, then soared by 50.11% to $28.2 million in 2020.
- Its Current Assets was $28.2 million in Q2 2020, compared to $9.5 million in Q1 2020 and $6.5 million in Q4 2019.